Projected Growth of the Global Veterinary CRO And CDMO Market to Reach $10.71 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the veterinary cro and cdmo market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Veterinary CRO And CDMO Market By The End Of 2029?

The market encompassing veterinary contract research organizations (CRO) and contract development and manufacturing organizations (CDMO) has seen robust expansion lately, projected to increase from its 6.97 billion U.S. dollars valuation in 2024 to reach 7.53 billion U.S. dollars by 2025, exhibiting a compound annual growth rate of 8.0%; this upward trajectory during the historical span is linked to factors such as escalating demands for adherence to regulations, the worldwide expansion of the animal health sector, greater investment in pharmaceutical creation for agricultural animals, and a rise in outsourcing activities undertaken by pharmaceutical corporations.

Anticipation surrounds the veterinary contract research organization and contract development and manufacturing organization sector, projecting considerable expansion across the forthcoming years; this market is slated to reach a valuation of $10.71 billion by the year 2029, reflecting a steady compound annual growth rate (CAGR) measured at 9.2%. This upward trajectory throughout the projected timeframe stems from several propelling factors, such as the escalating utilization of personalized medicine approaches, a heightened concentration on proactive health maintenance strategies, enhanced disease outbreak monitoring systems, greater readiness for urgent situations, and the growing intricacy associated with developing animal treatments. Key developments shaping this period involve the increasing tendency to contract out research and development activities, the blending of advanced technology into operations, the formation of strategic alliances and cooperative agreements, a growing commitment to environmentally conscious production methods, and the ongoing incorporation of digital tools across veterinary service delivery.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

Which Business Drivers Are Underpinning The Growth Of The Veterinary CRO And CDMO Market?

The trajectory of the veterinary Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) market is anticipated to accelerate, largely fueled by escalating capital allocation toward animal healthcare. This surge in financial commitment to animal well-being stems from heightened recognition of its significance and a corresponding rise in the need for both veterinary services and related commodities, which in turn bolsters the veterinary CRO and CDMO sectors. To illustrate this trend, data released in October 2023 by the American Pet Products Association (APPA), a US-based entity dedicated to fostering pet ownership and the pet product sector, revealed that spending on pet care within the United States climbed from $123.6 billion in 2021 to $136.8 billion the following year; consequently, greater investment in animal healthcare is set to be the catalyst for expansion within the veterinary CRO and CDMO market.

What Are The Principal Segment Types In The Veterinary CRO And CDMO Market?

The veterinary cro and cdmo market covered in this report is segmented –

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, market Approval And Post- marketing

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Subsegments:

1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization

2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting

3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services

4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance

5) By market Approval And Post- marketing: Regulatory Submissions, Pharmacovigilance, Post- marketing Surveillance

How Are Industry Trends Steering The Expansion Of The Veterinary CRO And CDMO Market?

A significant trend emerging within the veterinary Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) sectors involves a pronounced emphasis on pioneering new products, as firms in these spheres actively channel efforts into product development to secure and maintain their competitive standing; for example, in June 2022, Vetio, an American CDMO concentrating solely on animal health, secured promising decisions from regulatory bodies, receiving an Intention to Grant from the European Patent Office (EPO) and a Notice of Allowance from the United States Patent Office (USPTO) regarding its proprietary Starch-Free Soft Chew formulation intended for animal medical uses. This specialized Soft Chew Technology platform, precisely engineered for animal health requirements by Vetio, excels at incorporating one or more therapeutic agents into a superior dosage form appropriate for veterinary pharmaceuticals, notably featuring a manufacturing method and composition entirely devoid of both starch and extraneous water, thereby offering outstanding compatibility for actives susceptible to degradation from moisture.

Which Companies Are Contributing Significantly To The Veterinary CRO And CDMO Market Growth?

Major companies operating in the veterinary cro and cdmo market include Eurofins Scientific SE, Pharmaceutical Product Development Inc., Syneos Health Inc., Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited., Inotiv Inc., Promega Corporation, Aenova Group, Sai Life Sciences Ltd., Taconic Bioscience Inc., Avid Bioservices Inc., Frontage Laboratories Inc., Angion Biomedica Corp., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Triveritas Ltd., Cebiphar, Ondax Scientific UK Ltd., Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

Which Region Offers The Most Opportunity For Veterinary CRO And CDMO Market Expansion?

North America was the largest region in the veterinary CRO and CDMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary CRO and CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=12080&type=smp

Browse Through More Reports Similar to the Global Veterinary CRO And CDMO Market 2025, By The Business Research Company

Veterinary Infectious Disease Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Animal Antibiotics And Antimicrobials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-antibiotics-and-antimicrobials-global-market-report

Veterinary Antibiotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795